indications for glp 1 agonists GLP-1/GIP RA Summary Sheet and Beyond! Oral semaglutide (Rybelsus) is the

Digital technologies for delivering multidisciplinary weight-management services: early value assessment

Meier JJ

Orexigenic neurons, which stimulate appetite, produce neuropeptide Y (NPY) and agouti-related peptide (AgRP)

This article was previously distributed in the August 22, 2023, educational email of the Patient Safety Authority, available at About the Author Patient Safety Authority (patientsafety.pa.gov) is an independent state agency that oversees the Pennsylvania Patient Safety Reporting System (PA-PSRS), the largest database of its kind in the United States.

Cardiovascular Outcomes Trials of Incretin-Based Therapies

Should I Consider Metformin Therapy for Weight Loss in Patients With Obesity But Without Diabetes